Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02005172 · ClinicalTrials.gov registry record · NA
Validation of an iPhone-based Event Recorder for Arrhythmia Detection
A NA study of Arrhythmia, Palpitations, Lightheadedness, sponsored by University at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT02005172 is a NA study of Arrhythmia, Palpitations, Lightheadedness that has completed, run by University at Buffalo. The registered enrollment target is 38 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02005172, a NA study of Arrhythmia, Palpitations, Lightheadedness, has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we will evaluate the diagnostic yield of the new AliveCor device versus a 14 day event monitor with the use of both devices simultaneously. We will also examine by means of a questionnaire the compliance, ease of use and patient satisfaction for each device. Hypothesis: 1. The AliveCor monitor will be non-inferior to the 14 day event monitor with respect to diagnosis of the arrhythmia responsible for a patient's symptoms. 2. The AliveCor monitor will have better compliance and acceptability compared to the 14 day event monitor, and thus there will be a greater number of days with recordings from the AliveCor monitor.
Conditions Studied
Interventions
- DEVICE Alivecor monitor and 14 day event monitor
Study Locations (1)
New York
- Dent Towers - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02005172
The ClinicalTrials.gov registry entry for NCT02005172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arrhythmia, Palpitations, Lightheadedness appearing as the primary indexed condition, and to 1 intervention - of which Alivecor monitor and 14 day event monitor is the first listed.
NCT02005172 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02005172 about?
NCT02005172 is a clinical study titled "Validation of an iPhone-based Event Recorder for Arrhythmia Detection". In this study, we will evaluate the diagnostic yield of the new AliveCor device versus a 14 day event monitor with the use of both devices simultaneously. We will also examine by means of a questionnaire the compliance, ease of use and patient satisfaction for each device. Hypothesis: 1. The Alive...
What is the current status of trial NCT02005172?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2013-11. Estimated completion is 2016-05.
What conditions does trial NCT02005172 study?
This clinical trial studies the following conditions: Arrhythmia, Palpitations, Lightheadedness.
What interventions are being tested in trial NCT02005172?
The interventions under investigation include: Alivecor monitor and 14 day event monitor (DEVICE).
Who is sponsoring clinical trial NCT02005172?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02005172 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.